Business Process Outsourcing
PRODUCTS
-
Predict Genotoxic & Carcinogenic Endpoints to Meet ICH M7(R2) Guidelines
ACD/Impurity Profiling Suite predicts a variety of toxicological endpoints to help you assess the genotoxic and carcinogenic potential of impurities and degradants. Developed through a collaborative agreement with the US Food and Drug Administration (FDA), the software can be used as part of your ICH M7(R2) workflow—to help prepare regulatory submissions and remain compliant.
- Determine the ICH M7(R2) classification for impurities and degradants
- Predict 21 toxicological endpoints from structure; for mechanisms of hazardous activity including:
- Mutagenicity (AMES test and other procaryote and eucaryote test systems)
- Clastogenicity
- Other DNA damage
- Carcinogenicity
- Endocrine disruption mechanisms
- Identify potentially hazardous structural fragments responsible for carcinogenic and genotoxic activity
- Gain insight into the possible mechanisms of toxic effects
- Assess the reliability of predictions
-
Boost patient engagement. Simplify and reduce site workload. Enable real-time, local currency payments through the patient’s preferred method.
-
Scale up your viral vector or gene therapy manufacturing cost-effectively with HEKima Adherent, a QuickStart Media designed to simplify customization and accelerate development and production.
-
Patients shouldn’t have to jump through hoops. Discover an innovative portal that lets them handle travel and reimbursement directly—securely, simply, and without extra calls to the site.
-
Industry leading pharmacovigilance solutions from clinical development through post-approval.
WHITE PAPERS AND CASE STUDIES
-
Five Essentials For Accurate Oligonucleotide Chemistry
Explore five key areas in oligonucleotide chemistry where improvements will have a huge influence on your synthesis quality.
-
How A Strategic Partnership Drove Micro Molding Success
In micro-manufacturing, supplier choice significantly determines success. Explore how one company transformed a struggling production program into a 150-million-part success through trust, scalability, and true strategic partnership.
-
Scaling A Sterile Fill-Finish Program 4x Without Adding Complexity
Scaling sterile fill-finish operations requires balancing tight clinical timelines with flexibility. Single-use formulation systems eliminate major capital costs, reduce cleaning burdens, and speed turnarounds without sacrificing product quality.
-
Water Reclamation Facility Streamlines Equipment For Improved Function
A water reclamation facility in Carol Stream, Illinois, optimized its equipment layout using Blue-White’s FLEXFLO® M2 metering pumps and CHEM-FEED® wall mount systems, improving functionality, reducing piping complexity, and saving space for a more efficient operation.
-
Strategic Space Management
A pharmaceutical company facing storage space issues decided to outsource its reference samples to Q1 Scientific, a stability storage service provider, resulting in cost savings.
-
Development And Regulation Of Veterinary Monoclonals
Although veterinary mAbs have achieved commercial success, ongoing discussions and clinical developments surrounding them are expected to outline a clear regulatory pathway in the near future.
-
How To Unlock The Secret To Repeatable, Scalable Low Turnover
Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.
-
Overcoming Unexpected Obstacles In A Phase 1 Study
Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.
-
Reducing Cost Drivers And Improving Efficiency In CAR T Cell Manufacturing
Fragmented CAR T cell manufacturing workflows drive up costs and extend timelines. This case study quantifies what consolidating manufacturing and QC through automation actually delivers.
-
Hunting An Unexpected mAb Variant With LC‑MS
A tailored LC–MS approach enables sensitive detection and tracking of monoclonal antibody variants, supporting deeper product characterization and better control of quality‑impacting changes.
-
Oil & Gas Use Case: Permian Basin, Texas
Modern electrocoagulation provides a reliable alternative to deep-well disposal. By eliminating bacteria and heavy metals while preserving minerals like lithium, these self-cleaning systems deliver high-quality effluent for reuse, reducing seismic risks and operational costs.
-
Targeting Macular Degeneration With Stem Cell Therapy
A novel stem-cell therapy based upon iPSC-derived RPE cell transplantation was conceptualized as a promising new treatment for AMD and other retinal diseases.
NEWS
-
MIT Researchers Invent New Human Brain Model To Enable Disease Research, Drug Discovery11/5/2025
A new 3D human brain tissue platform developed by MIT researchers is the first to integrate all major brain cell types, including neurons, glial cells, and the vasculature, into a single culture.
-
YAKU: UC Chile-Trademarked Technology That Reuses Grey Water11/12/2025
A venture kickstarted at UC Chile, led by Valentina Veloso and Camila Cárdenas, with the support of the Office of Transfer and Development, is redefining water management with a natural bio-filtering system that purifies domestic wastewater from showers and washing machines.
-
Are You Ready For The New Water Reuse Regulations?2/13/2025
Understand how California’s new Title 22 regulations define the multi-barrier approach to potable reuse, and what that means for water treatment plants throughout the U.S.
-
Ocean Bacteria Team Up To Break Down Biodegradable Plastic3/16/2026
Biodegradable plastics could help alleviate the plastic waste crisis that is polluting the environment and harming our health.
-
Light Particles Prefer Company10/22/2025
As far as particles of light are concerned, the collective is more important than the individual. When they get to decide between two states, they will favor the one that many of their fellow particles have already adopted.